专利检索 ap:("Inturrisi, Charles, E." OR "Manfredi, Paolo L.") AND inv:"Manfredi, Paolo L." 第 1 页

1.

发明公开
COMPOUNDS FOR TREATMENT OR PREVENTION OF DISORDERS OF THE NERVOUS SYSTEM AND SYMPTOMS AND MANIFESTATIONS THEREOF, AND FOR CYTO-PROTECTION AGAINST DISEASES AND AGING OF CELLS, AND SYMPTOMS AND MANIFESTATIONS THEREOF 审中-公开

公开(公告)号：EP3576739A2

公开(公告)日：2019-12-11

申请号：EP18706021.5

申请日：2018-01-31

申请人： Manfredi, Paolo L. , Inturrisi, Charles, E.

发明人： Manfredi, Paolo L. , Inturrisi, Charles, E.

IPC分类号： A61K31/485 , A61P25/00

2.

发明授权
D-METHADONE FOR THE TREATMENT OF PSYCHIATRIC SYMPTOMS 有权

公开(公告)号：EP2906209B1

公开(公告)日：2018-06-20

申请号：EP13773543.7

申请日：2013-09-25

申请人： Inturrisi, Charles, E. , Manfredi, Paolo L.

发明人： Inturrisi, Charles, E. , Manfredi, Paolo L.

IPC分类号： A61K31/137 , A61P25/00 , A61P25/24

CPC分类号： A61K31/137 , A61K9/0019 , A61K45/06 , A61K2300/00

摘要： The present invention relates to a method of treating psychiatric symptoms in a subject having a NMDA receptor and a NE receptor which includes administering d-methadone, d-methadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, d-alpha-normethadol, l-alpha-normethadol, pharmaceutically acceptable salts thereof, or mixtures thereof, to the subject under conditions effective for the substance to bind to the NMDA receptor and NE receptor of the subject.

3.

发明公开
DAILY DOSAGE REGIMEN FOR TREATING DIABETES, OBSITY, METABOLIC SYNDROME AND POLYCYSTIC OVARY SYNDROME 审中-公开
标题翻译：每日剂量方案用于治疗糖尿病，肥胖症，代谢综合征和多囊卵巢综合征

公开(公告)号：EP1906934A1

公开(公告)日：2008-04-09

申请号：EP06786270.6

申请日：2006-07-03

申请人： Folli, Franco , Manfredi, Paolo L. , Gonzales, Gilbert R.

发明人： Folli, Franco , Manfredi, Paolo L. , Gonzales, Gilbert R.

IPC分类号： A61K9/20

CPC分类号： A61K31/155 , A61J1/035 , A61J7/04 , B65D75/327 , B65D75/36

摘要： A daily dosage regimen for treating diabetes, obesity and metaboiic syndrome includes a metabolic pill 16 and one or two biguanide hypoglycemic pills 12, 14 packaged together. The package 10, 18 can include a single day's regiment, or can include multiple days' regimen. This provides an effective method for treating diabetes, obesity and metabolic syndrome, as well as polycystic ovary syndrome.